FDA loosens pharmaceutical regs

The Food and Drug Administration (FDA) is loosening the regulatory controls for 13 pharmaceutical companies that will receive expedited entry for drugs they are importing into the United States.

As part of an FDA pilot program, these "highly vetted" companies will have more responsibility for regulating their own supply chains so the agency can focus more attention on preventing other, unapproved drugs that are misbranded and adulterated from crossing the border. 


Relief for 9/11 cancer survivors

The Obama administration is bolstering the medical benefits for some 9/11 responders and survivors who developed rare forms of cancer because they were exposed to the toxic fallout of the terrorist attacks.


Senate GOP: FDA-approved drug poses 'significant danger'

Senate Republicans are pushing the U.S. Food and Drug Administration (FDA) to withdraw support for a prescription drug they say poses a "significant danger" to the public. 

The Food and Drug Administration approved Zohydro last October. But the move came less than a year after one of the FDA's advisory panels warned against it because the painkiller contains high amounts of hydrocodone, a drug that government officials say is highly addictive and widely abused. 



Silica protections 'badly outdated,' liberal groups say

The Occupational Safety and Health Administration (OSHA) is working through more than 2,700 responses from business, labor and environmental groups about a rule that would protect workers from exposure to silica dust.

Labor and...